Metabolic and Epigenetic Regulation of Endoderm Differentiation

Yi Fang,Xiaoling Li

DOI: https://doi.org/10.1016/j.tcb.2021.09.002

IF: 21.167

2022-01-01

Trends in Cell Biology

Abstract:Metabolic reprogramming upon endoderm differentiation of embryonic stem cells (ESCs) is coupled with profound epigenetic changes. Epigenetic remodeling induces a permissive chromatin state for endodermal gene expression. Dynamics of H3K27 trimethylation during endoderm differentiation is modulated by PRC and demethylases. Histone crotonylation promotes endoderm differentiation of human ESCs in response to metabolic reprogramming. The endoderm, one of the three primary germ layers, gives rise to lung, liver, stomach, intestine, colon, pancreas, bladder, and thyroid. These endoderm-originated organs are subject to many life-threatening diseases. However, primary cells/tissues from endodermal organs are often difficult to grow in vitro. Human pluripotent stem cells (hPSCs), therefore, hold great promise for generating endodermal cells and their derivatives for the development of new therapeutics against these human diseases. Although a wealth of research has provided crucial information on the mechanisms underlying endoderm differentiation from hPSCs, increasing evidence has shown that metabolism, in connection with epigenetics, actively regulates endoderm differentiation in addition to the conventional endoderm inducing signals. Here we review recent advances in metabolic and epigenetic regulation of endoderm differentiation. The endoderm, one of the three primary germ layers, gives rise to lung, liver, stomach, intestine, colon, pancreas, bladder, and thyroid. These endoderm-originated organs are subject to many life-threatening diseases. However, primary cells/tissues from endodermal organs are often difficult to grow in vitro. Human pluripotent stem cells (hPSCs), therefore, hold great promise for generating endodermal cells and their derivatives for the development of new therapeutics against these human diseases. Although a wealth of research has provided crucial information on the mechanisms underlying endoderm differentiation from hPSCs, increasing evidence has shown that metabolism, in connection with epigenetics, actively regulates endoderm differentiation in addition to the conventional endoderm inducing signals. Here we review recent advances in metabolic and epigenetic regulation of endoderm differentiation. heritable changes that affect gene expression and phenotypes without alterations in the DNA sequence. Epigenetic mechanisms include DNA methylation and histone modifications. a multistep process to break down fatty acid-CoA to produce one molecule of acetyl-CoA each cycle. a series of biochemical reactions that convert glutamine to glutamate, and to α-ketoglutarate, which enters tricarboxylic acid cycle (TCA cycle). the metabolic pathway that breaks down glucose to pyruvate. No oxygen is required in the process and free energy released is used to form ATP and NADH. a type of human pluripotent stem cell generated directly from somatic cells by using the four specific factors (MYC, OCT3/4, SOX2, and KLF4). refers to the metabolisms, which include the folate and methionine cycles, to generate one-carbon units (methyl groups) for the synthesis of DNA, polyamines, amino acids, creatine, and phospholipids. a mitochondrial process, in which NADH or FADH2 transfers their electrons to O2 through a series of electron carriers to generate ATP. the potential of a stem cell to differentiate into any of the three germ layers, endoderm, mesoderm, or ectoderm. Pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and induced pluripotent stem cell (iPSCs), are stem cells with pluripotency. a family of evolutionarily conserved protein complexes that epigenetically remodel chromatin structures to silence gene expression. There are at least two separate protein complexes: the PcG repressive complex 1 (PRC1) which catalyzes monoubiquitin on histone H2A on lysine 119 (H2AK119Ub1), and the PcG repressive complex 2–4 (PRC2/3/4) among which PRC2 catalyzes H3K27me2/3. PRC2 complex consists of three core subunits: EZH2, EED, and SUZ12. EZH2 is the catalytic subunit that methylates H3K27, and EED binds H3K27me3 to enhance EZH2 activity. refers to the state of enhancers which are inactive for gene expression but are marked by multiple histone modifications and/or chromatin regulators for activation at chromatin level. mammalian embryonic stages before implantation, including the zygote resulting from fertilization of an oocyte by a spermatozoon; cleavage (mitotic division) of the zygote that results in 2-cell, 8-cell, 12–16-cell (blastomeres); compaction in which blastomeres adhere to each other to form the morula; and eventually blastocyst. Embryo implantation occurs on day 7 after fertilization in human, at E4.5 in mouse. a structure that forms on the dorsal face of an early developing embryo. The formation of primitive streak will then establish bilateral symmetry and initiate germ layer formation. a family of evolutionarily conserved complexes, remodeling nucleosomes and chromatin structures by hydrolyzing ATP. a series of biochemical reactions that convert acetyl-CoA and oxaloacetate to citrate, isocitrate, α-ketoglutarate, succinate, fumarate, malate, and back to oxaloacetate again. In this cycle, acetyl-CoA from degradation of glucose, fatty acids, or amino acids enters the TCA cycle to be further converted to CO2 and energy. Each turn of the TCA cycle generates 1 molecule ATP, 3 molecules NADH, and 1 mole FADH2. NADH and FADH2 then transfer their energy to electron transport chain. a core set of transcription factors that is the core for maintenance of the ES cell state and reprogramming of somatic cells to pluripotency. Three core pluripotency factors are Oct4, Sox2, and Nanog.